Home
>
National Drug Code (NDC)
>
EXTAVIA
EXTAVIA - 0078-0569-12 - (Interferon beta-1b)
Drug Information of EXTAVIA
| Product NDC: | 0078-0569 |
| Proprietary Name: | EXTAVIA |
| Non Proprietary Name: | Interferon beta-1b |
| Active Ingredient(s): | & nbsp; Interferon beta-1b |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of EXTAVIA
| Product NDC: | 0078-0569 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125290 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20090814 |
Package Information of EXTAVIA
| Package NDC: | 0078-0569-12 |
| Package Description: | 15 BLISTER PACK in 1 CARTON (0078-0569-12) > 1 KIT in 1 BLISTER PACK (0078-0569-61) * 3 mL in 1 VIAL, SINGLE-USE * 1.2 mL in 1 SYRINGE |
NDC Information of EXTAVIA
| NDC Code | 0078-0569-12 |
| Proprietary Name | EXTAVIA |
| Package Description | 15 BLISTER PACK in 1 CARTON (0078-0569-12) > 1 KIT in 1 BLISTER PACK (0078-0569-61) * 3 mL in 1 VIAL, SINGLE-USE * 1.2 mL in 1 SYRINGE |
| Product NDC | 0078-0569 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Interferon beta-1b |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20090814 |
| Marketing Category Name | BLA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
